MCKENNA, LONG & ALDRIDGE for ALLERGAN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 17, 2009 | $80,000 | Replaced |
| 1st Quarter - Amendment | Jun 9, 2009 | $80,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL CLERICI | — |
| DOUG FARRY | — |
| JENNIFER HANNESSCHLAGER | — |
| CHARLES RANDALL NUCKOLLS New | — |
| TED VAN DER MEID New | Counsel/Dir.Floor Operations - House Speaker |
Homeland Security HOM
public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL CLERICI | — |
| DOUG FARRY | — |
| JENNIFER HANNESSCHLAGER | — |
| CHARLES RANDALL NUCKOLLS New | — |
| TED VAN DER MEID New | Counsel/Dir. Floor Operations - House Speaker |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.